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number of autopsies in cancer patients has changed over a longer period of time and how often autopsies
provide a diagnosis of clinically undetected cancer. Data from the Cancer Registry Zurich consisting of
102,434 cancer cases among 89,933 deceased patients between 1980 and 2010 were analyzed by means of
descriptive statistics. The autopsy rate declined from 60 % in 1980 to 7 % in 2010. The total number
of autopsies performed decreased from 1179 in 1986 to 220 in 2010. Furthermore, there was also a
decline in the rate of newly detected tumours based on autopsy information. In 1980, the rate of newly
detected tumours through autopsy was 42 % compared with 2010, when the rate had declined to 17 %.
A consequence of the reduced autopsy rate is the reduction of incidental findings at autopsy in cancer
registration. However, this reduction has not negatively affected the total incidence of cancer. It seems
that the state-of-the-art diagnostic tools used for tumour detection are sufficiently reliable, allowing the
scientific community to trust the quality of data provided by cancer registries in spite of decreasing
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Abstract During the last decades, autopsy rates have dramat-
ically decreased in many countries. The Cancer Registry
Zurich, which exists since 1980, provides the opportunity to
address to what extent the number of autopsies in cancer pa-
tients has changed over a longer period of time and how often
autopsies provide a diagnosis of clinically undetected cancer.
Data from the Cancer Registry Zurich consisting of 102,434
cancer cases among 89,933 deceased patients between 1980
and 2010 were analyzed by means of descriptive statistics.
The autopsy rate declined from 60 % in 1980 to 7 % in
2010. The total number of autopsies performed decreased
from 1179 in 1986 to 220 in 2010. Furthermore, there was
also a decline in the rate of newly detected tumours based on
autopsy information. In 1980, the rate of newly detected tu-
mours through autopsy was 42 % compared with 2010, when
the rate had declined to 17 %. A consequence of the reduced
autopsy rate is the reduction of incidental findings at autopsy
in cancer registration. However, this reduction has not nega-
tively affected the total incidence of cancer. It seems that the
state-of-the-art diagnostic tools used for tumour detection are
sufficiently reliable, allowing the scientific community to trust
the quality of data provided by cancer registries in spite of
decreasing autopsy rates.
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Background
During the last decades, autopsy rates have dramatically de-
creased in frequency in Switzerland and many other countries
[1–3], due to new legislation, increase in the number of imag-
ing investigations [magnetic resonance imaging (MRI), com-
puted tomography (CT), positron emission tomography
(PET)] and tissue sampling. Many published studies [4–8]
on this subject focused on the evolution of the diagnostic error
rate.
The autopsy is an important quality tool in medical practice
[9], in particular, to evaluate the reliability of cancer incidence.
Burton et al. [4] investigated this topic and detected a signif-
icant discrepancy between clinical and autopsy diagnoses at a
relatively high level, with a discordance rate of 44 %. They
concluded that their findings were in accordance to previous
studies investigating clinical-pathological discrepancies, sim-
ilar as a more recent study from Grinberg et al. [5] and a study
performed in an intensive care unit by Pastores et al. [8].
Lundberg [6] goes one step further, in stating that clinical-
pathological discrepancies, not only restricted to tumours, in-
creased over the years and even called it “the hard times of
autopsy”. However, a different picture emerges in the study by
Schwanda-Burger et al. [7], who focused on two periods of
time series between 1972 and 2002 in Switzerland and report-
ed a significant reduction in diagnostic errors.
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A study [10] conducted in Malmö, Sweden, reported a
continuous decrease in the autopsy rate from 81 % in 1984
to 34 % in 1993. The conclusion was that the declining autop-
sy rate contributed to differences in the distribution of cause of
death and cancer incidence.
The goal of this investigation is to answer the following
key questions. Firstly, how has the number and rate of autop-
sies in cancer patients changed over a longer period of time?
Secondly, to what extent does the autopsy provide additional
information or a correction of the cancer diagnosis and how
often does the autopsy provide a diagnosis of clinically unde-
tected cancer? The Cancer Registry Zurich exists since 1980
and is the largest in Switzerland with more than 6000 incident
invasive cancer cases per year. Thus, it provides the opportu-
nity to analyze the impact of autopsy in verifying and optimiz-
ing cancer registry data over an extended period of time.
Methods
The cancer registry in the Canton of Zurich was established in
accordance with a government decision in 1980. The aim was
to cover all cancer cases emerging in the Canton of Zurich.
With a population of around 1.3 million inhabitants and an
annual accrual of more than 6000 new invasive cancer cases,
the Cancer Registry Zurich is the largest cancer registry in
Switzerland. In terms of organization, the registry is associat-
ed with the Institute of Clinical Pathology at the University
Hospital Zurich and the Epidemiology, Biostatistics and
Prevention Institute University of Zurich.
This study was based on the data collection of the Cancer
Registry Zurich. In the time period from 1980 to 2010, 102,
434 cancer cases diagnosed in 89,933 deceased patients were
documented. A single cancer was diagnosed in 78,853 pa-
tients, and 11,080 patients were diagnosed with more than
one cancer. If an individual was diagnosed with two or more
different malignant tumours within this period, each individ-
ual tumour localization was included in the calculation of
cancer prevalence, incidence and the comparison between in-
cidence and the impact of autopsy on incidence. In calculating
the overall autopsy number and rate, only, the first time, a
tumour occurred was included.
The main basis for the acquisition of new cancer cases is
pathology reports from public and private pathology and
haematology institutions in the Canton of Zurich together with
the information on Zurich cancer patients from cancer regis-
tries of other cantons. This information is supplemented by
comparisons with hospital statistics, which are created by all
hospitals nationwide for the Federal Office of Statistics. Infor-
mation on autopsies was collected from pathology and foren-
sic medicine institutes performing autopsies. Cancer cases in
the Canton of Zurich are registered with presumed consent,
and registration is based on a decision by the Zurich
Government Council from 1980 and the general registry ap-
proval by the Federal Commission of Experts for professional
secrecy in medical research from 1995. All data were used
anonymously in this analysis, and no approval from the ethical
committee of the Canton of Zurich was necessary.
Data are presented as absolute numbers or percentages. To
examine the change in newly detected tumours through au-
topsies, we computed the percentage of incident tumours de-
tected by autopsy as a 3-year moving average to smooth the
observed changes. All statistical analyses were performed
using Stata SE 12.
Results
In the Canton of Zurich, the autopsy rate among patients who
died of cancer declined from 60 % in 1980 to 7 % in 2010
(Table 1). The total number of autopsies performed decreased
from 1179 in 1986 to 220 in 2010.
In 1980, 426 autopsies were performed on men and only
254 on females. Even if these absolute numbers are related to
the gender-specific differences in the number of autopsies
performed, a remarkable gender-specific difference of almost
10% emerges. Of all cancer-associated deaths in men in 1980,
64 % were autopsied, but this was the case in only 55 % of
cancer deaths in women. This gender-associated difference in
the autopsy rate decreased over time, to 7.3 % in men and
5.8 % in women in 2010.
To address the question to what extent autopsy provides
additional information or a correction of the cancer diagnosis
and to what extent the autopsy does provide a diagnosis of
clinically undetected cancer, we examined the number of can-
cers detected based on an autopsy in relation to all autopsies on
patients who died of cancer (Fig. 1). The number of autopsies
performed on cancer patients reached a peak of 1179 in 1986.
However, the number of newly detected tumours did not in-
crease during this period. After 1986, the number of autopsies
decreased, along with a decrease in tumours newly detected at
autopsy. To better understand this development, we examined
the change in the number of newly detected tumours by means
of an autopsy as a percentage of the incident cases at the level
of individual tumour entities (Fig. 2). The analysis focused on
tumour entities for which autopsy information contributed at
least 15 % to the incidence rate at the beginning of data collec-
tion and for which the tumour-specific trend was in accordance
with the overall trend (for the latter reason, neoplasms of the
small intestine and larynx were excluded). These criteria were
met by five tumour entities: liver, gallbladder and biliary tracts,
pancreas, prostate, thyroid gland and kidney. In 1980, the dis-
covery rate at autopsy for these five entities was about 15 %,
which then more or less steadily decreased to less than 3 % in
2010. This, however, did not affect the actual number of cases
diagnosed during this time period (Fig. 3).
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Discussion
Our data support the global trend in declining autopsy rates and
total number of autopsies performed [1]. In 30 years, the rate of
autopsies performed on patients, who died of cancer, declined
from 60% in 1980 to 7 % in 2010. This decrease is even more
significant than the decline of the overall autopsy rate in
Switzerland from 13 % in 1993 to < 4 % in 2012 indicated
by a recent publication [11]. A variety of causes can be consid-
ered for the continuously decreasing autopsy rates. On the one
hand, scientific progress along with the introduction of new
diagnostic tools allows to detect cancer with a high reliability;
on the other hand, changes in legislation have had an important
impact. Chariot et al. [12] conclude that the introduction of a
new bioethics law in 1994 contributed markedly to the decline
of the autopsy rate. In Zurich, a legal change occurred in 2005 in
the procedure for obtaining permission to perform an autopsy,
but our results indicate that the decrease in the number of autop-
sies performed started much earlier and this legal change did not
significantly change the trend in declining autopsy rates in the
following years. Another possible reason is where patients die,
for which a study [10] fromMalmö, Sweden, provides evidence.
This retrospective study investigated causes and consequences
of the decline with a specific focus on cancer incidence. It













Autopsy in men in %






Autopsy in women in %
related to all female patients
1980 1127 680 60.34 663 426 64.25 464 254 54.74
1981 1802 871 48.34 1068 538 50.37 734 333 45.37
1982 2144 965 45.01 1209 567 46.90 935 398 42.57
1983 2422 1023 42.24 1380 618 44.78 1042 405 38.87
1984 2520 1032 40.95 1386 607 43.80 1134 425 37.48
1985 2623 1127 42.97 1494 672 44.98 1129 455 40.30
1986 2711 1179 43.49 1537 716 46.58 1174 463 39.44
1987 2857 1084 37.94 1571 617 39.27 1286 467 36.31
1988 2911 1051 36.10 1629 606 37.20 1282 445 34.71
1989 2981 1127 37.81 1697 682 40.19 1284 445 34.66
1990 2981 1014 34.02 1689 600 35.52 1292 414 32.04
1991 2996 949 31.68 1662 559 33.63 1334 390 29.24
1992 3070 975 31.76 1715 548 31.95 1355 427 31.51
1993 3039 793 26.09 1663 466 28.02 1376 327 23.76
1994 3009 675 22.43 1640 378 23.05 1369 297 21.69
1995 2859 647 22.63 1568 415 26.47 1291 232 17.97
1996 2778 642 23.11 1518 392 25.82 1260 250 19.84
1997 3329 627 18.83 1817 372 20.47 1512 255 16.87
1998 3258 584 17.93 1813 369 20.35 1445 215 14.88
1999 3153 574 18.20 1767 356 20.15 1386 218 15.73
2000 3139 499 15.90 1687 289 17.13 1452 210 14.46
2001 3088 451 14.60 1685 271 16.08 1403 180 12.83
2002 3077 461 14.98 1666 274 16.45 1411 187 13.25
2003 3157 364 11.53 1748 215 12.30 1409 149 10.57
2004 3213 361 11.24 1734 224 12.92 1479 137 9.26
2005 3330 339 10.18 1840 207 11.25 1490 132 8.86
2006 3215 317 9.86 1778 210 11.81 1437 107 7.45
2007 3331 274 8.23 1788 171 9.56 1543 103 6.68
2008 3200 230 7.19 1785 151 8.46 1415 79 5.58
2009 3286 218 6.63 1762 140 7.95 1524 78 5.12
2010 3327 220 6.61 1860 135 7.26 1467 85 5.79
The total number of autopsies performed broken down by sex and the proportion of the total number of autopsies performed broken down by gender
from 1980 to 2010. Each patient occurs only once, regardless of whether the patient was initially attributed to one or more tumour diagnoses
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provides a useful reference point for our own analysis because
of the comparable framework with regard to socioeconomic
structures. Their results indicate that patients who died in a
nursing home less often underwent an autopsy than patients
who died in a hospital. In Malmö, the percentage of people
dying in nursing homes increased between 1984 and 1993
from 1 to 29 %. This development mirrors the declining au-
topsy rate in Malmö. The authors conclude that this change in
where patients die is the most important explanation of the
declining autopsy rate in Malmö. This is also the conclusion
of a US study [13]. Since we were more focused on the
consequences than on the causes of the declining autopsy rate,
we did not investigate this as a possible explanation for the
decline. However, most citizens of Zurich died in hospitals
and nursing homes in 2010 [14]. Based on the similarities in
socioeconomic structures between Sweden and Switzerland, it
is likely that this observation explains a part of the decrease in
autopsy rate in our study.
Only three studies [15–17] that investigated gender differ-
ences in autopsy rate have been published. These studies in-
dicate that there is a difference by sex, i.e. a higher autopsy
rate in men than in women, but they were not able to identify
possible causes for this difference. However, these studies
describe gender selection trends in autopsy not limited to can-
cer cases, but for the whole spectrum of fatal medical
conditions.












Fig. 2 The development of the initial detection rate for tumour entities
for which the autopsy was in the beginning of the data collection of a
certain relevance for the incidence. Summarized with “moving averages
of 3 years” with the aim of enhancing the clarity of the figure. y-axis
incidence share of the autopsy in percentage, x-axis year
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Kircher et al. [15] observed that non-white men who died at
20 to 29 years of age were the most likely group to undergo an
autopsy. The autopsy rate was not proportional to the major
categories of the underlying cause of death. Deaths due to trau-
ma accounted for a larger proportion of all autopsies (25 %)
than of all deaths (6 %), and this difference was even called the
“epidemiological distortion factor: trauma associated death” by
the authors [15]. Since we focused our study on cancer-
associated deaths, we cannot transfer this approach to our data.
In order to find convincing explanations for this phenomenon,
further and more specific investigations targeting the discrepant
autopsy rates associated with sex are required.
We examined whether the decline in autopsy rates affected
the number of newly detected cancers and cancer rates in
general. We indeed observed a reduction in cancer cases de-
tected by autopsy of the tumour entities for which at least
15 % of cases had been detected by autopsy at the beginning
of the observation period (liver/gallbladder/biliary tract, pan-
creas, prostate, thyroid gland, kidney). Lindström et al. [10]
argued that a reduced autopsy rate might lead to a reduction of
incidental findings at autopsy, which in turn might affect the
incidence of several types of cancer. He based this on a com-
parison of the seven tumour sites (stomach, small intestine,
biliary tract and liver, prostate, nervous system, thyroid gland
and endocrine glands) for which incidental findings at autopsy
contributed to more than 20 % of the incidence in 1984. The
decline in autopsy rate was associated with a decline in the
number of cases for six of these seven entities. Our results,
based on changes in the incidence of the cancer entities for
which autopsies provided about 15 % of cases, only partly
confirm the results of the Malmö study. In the Canton of
Zurich, the incidence of prostate cancer increased consider-
ably in the past 30 years, whereas the incidence of the other
tumour entities, for which autopsies contributed considerably
to the incidence rate, remained stable or did not decrease
markedly during the past 30 years (see Fig. 3 and [18]). A
possible explanation for this phenomenon is the emergence
of the PSA test in the early 1990s, which leads worldwide to
an increase in prostate cancer incidence [19]. The impact of
PSA testing on the detection rate of prostate cancer at autopsy
was investigated in a study by Konety et al. [20]. Their find-
ings indicate that compared with the pre-PSA era, the preva-
lence of latent cancers only detected at autopsy had signifi-
cantly decreased. The cancers only detected by autopsy in the
pre-PSA era were found to be grossly invading adjacent struc-










































































































































Fig. 3 The development of total incident cancer cases for tumour entities
for which the autopsy was in the beginning of the data collection of a
certain relevance for the incidence. y-axis incidence, x-axis year. Under-
registration of prostate cancer due to limited access to two pathology
institutes (4–10 %) occurred between 2007 and 2010
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the PSA era were found to extend grossly beyond the prostate.
This can partly be attributed to different patient populations,
but most of all, to different methods of tissue sampling. The
rate of prostate cancer in the pre-PSA era was highest in stud-
ies in which the whole prostate was cut in serial sections. The
frequency of prostate cancer was clearly lower in studies in
which only one or a few prostate sections were histologically
examined at autopsy. Scott et al. [21] showed that serial sec-
tioning of the whole prostate can double the number of detect-
ed prostate cancers as compared to routine procedures. This
suggests that a considerable number of microscopic carcino-
mas remain undetected in routine autopsy series. A similar
phenomenon can be attributed to our findings of thyroid can-
cer, because the thyroid is not completely embedded to search
for small papillary cancers.
Long-term trends differed between men and women with
increasing age-adjusted incidence rates of liver, thyroid and
pancreatic cancer among women, but not men. Thus, it ap-
pears that decreasing autopsy rates were only of marginal
influence on cancer incidence rates. Rather, new sophisticated
diagnostic tools appear to contribute to increased detection
and diagnosis even in the context of decreasing autopsy rates.
On this basis, we conclude that the incidence data for the
Cancer Registry Zurich is a reliable reference for social, eco-
nomic and political purposes. Despite the fact that the quality
of our data was probably not severely affected by the declining
autopsy rate, the autopsy is still the only tool that provides
absolute certainty about the true nature of death, because it
is the reference mark for all upstream diagnostic measures.
The strength of our study is the long-standing data collec-
tion of the cancer registry in the Canton of Zurich and the large
number of cases. Data quality of the Cancer Registry Zurich is
considered to be good according to the rates of cases known
by death certificate only (DCO), which were always below
5 % during the years 2000 to 2010, and the proportions of
histologically verified cancer cases, which varied between 92
and 96% during the years 2000 to 2010. This means that these
quality markers were always below, respectively, within the
internationally defined limits.
Despite this strength, some limitations of our database have
to be mentioned. On the one hand, for resource reasons and
limited access to data, it is not known for all deaths whether an
autopsy had been performed or not (10,208 cancer deaths).
This affects, in particular, the 1990s and the year 2006. How-
ever, the percentage of newly detected tumours was similar in
these years compared with the other years. On the other hand,
only minimal information about the autopsy results was avail-
able in some cases. These cases were labelled as “autopsy was
performed, but no further information available” [“Autopsie
vorhanden, NNB”]. Of the 89,933 cancer deaths, 13,875 fall
into this category. This, however, does not affect our results
because in case a tumour is detected during autopsy, this case
will be reported to the cancer registry anyhow.
Our data do not allow us to address the question which
methods were used to diagnose a tumour in our series of
patients. However, in data from 1972, 1982, 1992 and 2002,
a significant increase in the number of diagnostic procedures
used including CT investigations, biopsies and fine-needle
aspirations, is clearly documented in a study conducted to
examine discrepancies between clinical and autopsy diagno-
ses in the University Hospital Zurich [7]. This study showed
that the increased use of modern investigation techniques was
associated with significantly increased sensitivity and accura-
cy of the diagnosis of cancer.
In conclusion, our study confirms the global trend towards
decreasing autopsy rates. A consequence of this development
is a reduction in the frequency of an incidental finding of
cancer at autopsy. In contrast to a previous study from Sweden
[10], this does not appear to have a negative impact on the
incidence of cancer in our statistical investigations. In spite of
decreasing autopsy rates, the quality of cancer registries is
solid. Nonetheless, autopsies remain to be an important mea-
sure to ensure the reliability of mortality statistics and the
correct classification of the cause of death. A continuing de-
crease in autopsy rates might result in failure to detect homi-
cide [22]. Furthermore, the autopsy remains to be the gold
standard in terms of quality control for diagnosis [3] and an
important tool for the education of medical students [23].
Funding None.
Conflict of interest None.
Author’s contributions UB performed the statistical analysis and
drafted the manuscript. HM, SD and SR participated in the design of
the study. SD and DK coordinated the study and were responsible for
data collection and preparation. All authors proofread the manuscript
critically and approved the final manuscript.
References
1. Shojania KG, Burton EC, McDonald KM, Goldman L. The autopsy
as an outcome and performance measure. Evidence report/
technology assessment (summary). 2002;(58):1–5.
2. Start RD, Firth JA, Macgillivray F, Cross SS, Road BH (1995) Have
declining clinical necropsy rates reduced the contribution of necropsy
to medical research? J Clin Pathol 48(5):402–404
3. Xiao J, Krueger GRF, Buja LM, Covinsky M (2009) The impact of
declining clinical autopsy: need for revised healthcare policy. Am J
Med Sci 337(1):41–46
4. Burton EC, McDonald KM, Goldman L, Page P (2003) Changes in
rates of autopsy-detected. JAMA 289(21):2849–2856
5. Grinberg LT, da Silva Ferraz LF, Galtarossa Xavier AC, Nascimento
Saldiva PH, Mauad T (2008) Clinico-pathological discrepancies in
the diagnoses of solid malignancies. Pathol Res Pract 204(12):867–
873
642 Virchows Arch (2015) 466:637–643
6. Lundberg GD (1998) Low-tech autopsies in the era of high-tech
medicine: continued value for quality assurance and patient safety.
JAMA 280(14):1273–1274
7. Schwanda-Burger S, Moch H, Muntwyler J, Salomon F (2012)
Diagnostic errors in the new millennium: a follow-up autopsy study.
Mod Pathol 25(6):777–783
8. Pastores SM, Dulu A, Voigt L, Raoof N, Alicea M, Halpern NA
(2007) Premortem clinical diagnoses and postmortem autopsy find-
ings: discrepancies in critically ill cancer patients. Crit Care 11(2):
R48
9. Gradistanac T, Wittekind C (2011) Autopsy as a tool for quality
assurance: Leipzig. Der Pathologe 32(Suppl 2):287–291
10. Lindström P, Janzon L, Sternby NH (1997) Declining autopsy rate in
Sweden: a study of causes and consequences in Malmö. Sweden. J
Intern Med 242(2):157–165
11. Bode PK, Cathomas G, Vogt P, Moch H (2014) Klinische Autopsie.
Praxis 103(2):65–71
12. Chariot P, Witt K, Pautot V, Porcher R, Thomas G, Zafrani ES,
Lemaire F (2000) Declining autopsy rate in a French hospital: phy-
sicians’ attitudes to the autopsy and use of autopsy material in re-
search publications. Arch Pathol Lab Med 124(5):739–745
13. Nemetz PN, Ludwig J, Kurland LT (1987) Assessing the autopsy.
Am J Pathol 128(2):362–379
14. Statistik Stadt Zürich (2012) Statistisches Jahresbuch der Stadt
Zürich, p. 72
15. Kircher T, Nelson J, Burdo H (1985) Descriptive epidemiology of the
autopsy in Connecticut, 1979-1980. Arch Pathol Lab 109(10):904–909
16. Nemetz PN, Ballard DG, Beard CN, Ludwig J, Tangalos EG,
Kokmen E, Weigel KM, Belau PG, Bourne WM, Kurland LT
(1989) An anatomy of the autopsy, Olmstead County, 1935 through
1985. Mayo Clin Proc 64:1055–1064
17. Cameron HM, McGoogan E, Clarke J, Wilson BA (1977) Trends in
hospital necropsy rates: Scotland 1961-74. Br Med J 1(6076):1577–
1580
18. Gutzwiller F, Moch H, Probst-Hensch M. Institut für Sozial- und
Präventivmedizin der Universität Zürich (2009, Hrsg.): Krebs im
Kanton Zürich. Kurzbericht des Krebsregisters
19. Baade PD, Youlden DR, Krnjacki LJ (2009) International epidemi-
ology of prostate cancer: geographical distribution and secular trends.
Mol Nutr Food Res 53(2):171–184
20. Konety BR, Bird VY, Deorah S, Dahmoush L (2005) Comparison of
the incidence of latent prostate cancer detected at autopsy before and
after the prostate specific antigen era. J Urol 174(5):1785–1788
21. Scott RJ, Mutchnik DL, Laskowski TZ (1996) Carcinoma of the
prostate in elderly men: incidence, growth characteristics and clinical
significance. J Urol 101:602–607
22. Gaensbacher S, Waldhoer T, Berzlanovich A (2012) The slow death
of autopsies: a retrospective analysis of the autopsy prevalence rate in
Austria from 1990 to 2009. Eur J Epidemiol 27:577–580
23. Bamber AR, Quince TA, Barclay SI, Clark JD, Siklos PW,Wood DF
(2014) Medical student attitudes to the autopsy and its utility in med-
ical education: a brief qualitative study at one UK medical school.
Anat Sci Educ 7(2):87–96
Virchows Arch (2015) 466:637–643 643
